#Canada #Toronto #Transcriptomics #Xtalks #DRUG-seq

Webinar: Profiling Biology at Scale with DRUG-seq

Overview

Join us for an enlightening free webinar titled Profiling Biology at Scale with DRUG-seq: From Mechanisms to Safety, hosted by Xtalks on November 14, 2025, at 11 AM EST. This session will delve into how transcriptomics assays are transforming the landscape of data-driven drug discovery, offering invaluable insights into various biological mechanisms and safety evaluations.

What to Expect

In this session, attendees will broaden their understanding of how high-throughput transcriptomics can facilitate compound profiling in primary human cells. A significant focus will be on mechanism-of-action clustering and pathway analysis that can lead to the identification of drug efficacy and safety. The expert panel, featuring leaders from Ginkgo Datapoints, will explore essential topics including:

• - Mechanism-of-Action Clustering: Understanding how to group compounds based on their biological effects.
• - Pathway Analysis: Analyzing how different therapeutic paths can be categorized and evaluated using advanced methodologies.
• - Off-Target Effects in RNAi Therapeutics: Gaining insights into how transcriptomic responses can illuminate unforeseen impacts of treatments, moving beyond standard measurements.
• - Data-Rich Screening: Discussing the significance of having a robust dataset that informs on both breadth and depth in early-stage research.

Featured Speakers

The webinar will feature insights from:

• - George Pilitsis, Director of Product, Ginkgo Datapoints
• - Ayla Ergun, Senior Director, Computational Biology and AI
• - Kurt Cox, Senior Engineer

These experts will present how data-driven approaches are reshaping traditional drug discovery methods, enabling researchers to achieve a balance between depth of biological understanding and screening breadth.

The Challenge Addressed

Historically, drug discovery frameworks have faced the dilemma of sacrificing biological resolution for broad screening capacities. This webinar seeks to address this challenge through a discussion on high-throughput transcriptomics assays, which allow for comprehensive gene expression profiling on an industrial scale. Attendees will learn how these innovative methodologies make it feasible to discover therapeutic mechanisms, analyze pathways, and evaluate safety effectively and efficiently.

Registration Details

Don’t miss this opportunity to elevate your understanding of drug discovery! Click here to register for the event and learn more about how transcriptomics is paving the way for novel approaches in drug development. The session is tailored for professionals across life sciences, including those engaged in pharmaceutical, biotech, and academic research sectors.

Make sure to set your alarms for this exciting session on November 14, 2025, hosted by Xtalks, a trusted provider of educational content for the global life science community. Join us to uncover the transformative potential of transcriptomics in advancing drug discovery practices today.